Director of Future Technology Platforms at US NGO think tank the Special Competitive Studies Project Abigail Kukura sat for an exclusive interview with The Yuan’s Andrii Buvailo - pharma analyst and BiopharmaTrend.com co-founder - and read her auguries for US biotech’s hereafter.

The rise of AI and the digital age are driving silent yet comprehensive change in Brazilian healthcare, with profound implications and innovative progress in digital health to benefit both doctors and their patients, says radiologist and healthcare executive Dr Gustavo Meirelles.

The Yuan is proud to unveil The Yuan Project, its latest initiative to help bring its online community of global experts together, connect, and share ideas as they seek to achieve new breakthroughs in the field of medical AI.

AI has brought about a remarkable transformation in the realm of drug discovery, which was previously plagued by inefficiency and a significant failure rate. The historical inefficiencies in drug discovery are swiftly becoming a thing of the past, and the repercussions for the healthcare industry are monumental, as highlighted by Dr Dilraj Kaur, a bioinformatic scientist at the Institute of Cancer Research in London.

5G technology is now ubiquitous, but its applications extend beyond mobile networks. AVs are one example and 5G and its successors will be a big reason why if they ever become mainstream, says Purva Joshi, a PhD candidate in Healthtech at the University of Pisa.